CRC
IRMD icon

Curi RMB Capital’s iRadimed IRMD Stock Holding History

Curi RMB Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
+18,495
New +$1.85M 0.03% 355

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Curi RMB Capital's IRMD Position: Q1 2026 in Review

Curi RMB Capital opened a new position in iRadimed (IRMD) in Q1 2026: 18,495 shares worth $1.78M. The stake represents 0.03% of the portfolio and ranks #355 among its holdings.

228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Curi RMB Capital held 18,495 shares of iRadimed worth $1.78M as of Q1 2026.
  • iRadimed was a new Curi RMB Capital position in Q1 2026.
  • iRadimed made up 0.03% of Curi RMB Capital's portfolio in Q1 2026, its #355 holding.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.